Javascript must be enabled to continue!
Introducing an argonaute-facilitated PCR platform
View through CrossRef
AbstractArgonaute proteins are characterized by highly efficient guide DNA/RNA-directed binding to target nucleic acids with high fidelity. Employing this feature, we designed an argonaute-facilitated PCR platform by making use of an argonaute derived from Mesorhizobium japonicum (MejAgo) which does not carry nuclease activity and exposes the 3’ end of guide DNA when binding. Each reaction cycle of the MejAgo-PCR platform consists of a denaturing step and a polymerase-mediated extension step, omitting the annealing step required by the traditional PCR. More importantly, MejAgo-PCR could significantly improve the sensitivity of PCR in template detection due to the argonaute-facilitated pairing between guide DNA/primer and template. Thus, an argonaute-facilitated PCR has the potential to be developed as an advanced PCR platform with higher sensitivity and efficiency.
Cold Spring Harbor Laboratory
Title: Introducing an argonaute-facilitated PCR platform
Description:
AbstractArgonaute proteins are characterized by highly efficient guide DNA/RNA-directed binding to target nucleic acids with high fidelity.
Employing this feature, we designed an argonaute-facilitated PCR platform by making use of an argonaute derived from Mesorhizobium japonicum (MejAgo) which does not carry nuclease activity and exposes the 3’ end of guide DNA when binding.
Each reaction cycle of the MejAgo-PCR platform consists of a denaturing step and a polymerase-mediated extension step, omitting the annealing step required by the traditional PCR.
More importantly, MejAgo-PCR could significantly improve the sensitivity of PCR in template detection due to the argonaute-facilitated pairing between guide DNA/primer and template.
Thus, an argonaute-facilitated PCR has the potential to be developed as an advanced PCR platform with higher sensitivity and efficiency.
Related Results
Abstract 2113: A wild-type-blocking reference sequence enhances COLD-PCR and enables fast amplification and high enrichment of all types of low-prevalence unknown mutations
Abstract 2113: A wild-type-blocking reference sequence enhances COLD-PCR and enables fast amplification and high enrichment of all types of low-prevalence unknown mutations
Abstract
Background: Molecular profiling of somatic mutations in cancer often requires the identification of low-prevalence DNA mutations in an excess of wild-type (...
Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic
Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic
Abstract
Background
Over the course of the COVID-19 pandemic, laboratories worldwide have been facing an unprecedented increase in demand for PCR testing because of the hi...
Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic
Flexible upscaling of laboratory PCR testing capacity at the Robert Koch Institute during the SARS-CoV-2 pandemic
Abstract
Background
Over the course of the COVID-19 pandemic, laboratories worldwide have been facing an unprecedented increase in demand for PCR te...
Comparison of Three Molecular Methods for the Detection and Speciation of Five Human Plasmodium Species
Comparison of Three Molecular Methods for the Detection and Speciation of Five Human Plasmodium Species
In this study, three molecular assays (real-time multiplex polymerase chain reaction [PCR], merozoite surface antigen gene [MSP]-multiplex PCR, and the PlasmoNex Multiplex PCR Kit)...
Ανάπτυξη μικροδιατάξεων (chips) για την ανάλυση νουκλεϊκών οξέων
Ανάπτυξη μικροδιατάξεων (chips) για την ανάλυση νουκλεϊκών οξέων
Η ανάπτυξη μικροδιατάξεων (chips) για χημική ανάλυση αποτελεί ένα νέο και ταχύτατα εξελισσόμενο πεδίο με πληθώρα εφαρμογών στη Χημεία και τη Βιολογία. Η κατασκευή των αναλυτικών μι...
2334. Saliva Screening for Congenital Cytomegalovirus Infection in the Neonatal Intensive Care Unit: Beware!
2334. Saliva Screening for Congenital Cytomegalovirus Infection in the Neonatal Intensive Care Unit: Beware!
Abstract
Background
Congenital cytomegalovirus (cCMV) infection is the most common cause of non-genetic sensorineural hearing lo...
The Impact of Vaccination on RT-PCR Cycle Threshold Values for COVID-19: Insights for Future Pandemic Preparedness
The Impact of Vaccination on RT-PCR Cycle Threshold Values for COVID-19: Insights for Future Pandemic Preparedness
Abstract
Amid the COVID-19 surge, effective management hinges on precise diagnostic techniques, particularly through the comparison of results among vaccinated and unvaccin...
De-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel weekly in HR-/HER2+ early breast cancer: ADAPT-HR-/HER2+ biomarker and survival results.
De-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel weekly in HR-/HER2+ early breast cancer: ADAPT-HR-/HER2+ biomarker and survival results.
503 Background: Optimal use of de-escalated, particularly chemotherapy(CT)-free, neoadjuvant regimens in HER2+ early breast cancer (EBC) is currently unclear as there are limited ...

